Tag: Cirrhosis
Antivirals Aid HBeAg-Negative Chronic Hepatitis B Patients
Findings seen for those with normal alanine transaminase and especially for patients with HBV DNA ≥2,000 IU/mL
Markers of Inflammation Can Predict 180-Day Mortality in Cirrhosis
20 markers of inflammation correlated with 180-day mortality; no correlations observed with liver-related admissions
Significant Impairments Found in Taste, Smell for Cirrhosis Patients
Stroop and the psychometric hepatic encephalopathy score impairment also worse for patients versus controls
High-Risk Patients Awaiting Liver Transplant Benefit Most From Living Donors
Benefit was most evident in wait-listed cirrhosis patients with moderate-to-severe frailty
Serum Ammonia, Hospital Mortality Linked in ICU Cirrhosis Patients
Model with serial ammonia measured on ICU days 1 and 3 predicted hospital mortality with reasonably good discrimination
Racial Disparities Seen Among Hospitalized Patients With Decompensated Cirrhosis
Findings seen for Black and Hispanic versus White patients for liver transplantation and mortality
Modified Child-Turcotte-Pugh Score Performs Well in Decompensated Cirrhosis
aCTP, in which plasma ammonia replaces hepatic encephalopathy, improves discrimination of transplant-free survival
ChatGPT Provides Some Helpful Responses for Liver Diseases
However, responses were lower for comprehensiveness and knowledge of guideline variations
Ursodeoxycholic Acid Cuts SARS-CoV-2 Infection, Severity
UDCA exposure among participants with cirrhosis tied to reduced odds of developing SARS-CoV-2 infection
Model Developed for Predicting Disease Progression in Hep B Liver Cirrhosis
Model can predict acute-on-chronic liver failure in patients with hepatitis B liver cirrhosis-acute decompensation
